Click on the Lecture title to view video
#
Day 1 Proceedings Author
     
Session 1- Complications of Cirrhosis  
1
Acute kidney injury in patients with cirrhosis: Updated guidelines of the International Club of Ascites Paolo Angeli
2
Refractory ascites and hepatic hydrothorax – Management S.K Acharya
3
Management of variceal bleed beyond pharmacotherapy D N Reddy
Session 2- Debate  
1
Beta-blockers are safe in decompensated cirrhosis of liver (for) Swastik Agrawal
2
Beta-blockers are safe in decompensated cirrhosis of liver (against) Anil C Anand
Session 3- NAFLD  
1
Gut microbiota and NAFLD Atul Sachdev
2
Is simple steatosis really benign? Ajay Duseja
Session 4- Viral Hepatitis  
1
Emerging therapies for chronic hepatitis B S.K Sarin
2
Immunotherapy for HBV SMF Akbar
3
How to follow-up HCV patients after “cure”? Anil Arora
4
Resistance-associated variants in chronic hepatitis C patients treated with DAAs Rakesh Aggarwal
Session 5- EASL/INASL Session  
1
Hepatitis B: current guidelines and future options for cure Massimo Colombo
2
Hepatitis E: from epidemiology to management Rakesh Aggarwal
3
Hepatitis C: the EASL guidelines and newest data Xavier Forns
4
Hepatitis C: Current and future burden in India VA Saraswat
5
NAFLD: cofactor for viral hepatitis and evolving disease entity Frank Tacke
Session 6- Liver Clinics (Case based discussion): 3 Cases-  
1
Liver Clinics (Case based discussion): 3 Cases- Patrick Kamath
Session 7- Symposium on Hepatic Encephalopathy  
1
AASLD/EASL guidelines on HE and future treatment of HE Jasmohan Bajaj
2
Management of difficult to treat/refractory hepatic encephalopathy Barjesh Sharma

   © 2017 INASL. All rights reserved.